| Phase III, randomized study of atezolizumab plus bevacizumab and chemotherapy in patients with EGFR-or ALK-mutated non–small-cell lung cancer (ATTLAS, KCSG-LU19-04) S Park, TM Kim, JY Han, GW Lee, BY Shim, YG Lee, SW Kim, IH Kim, ... Journal of Clinical Oncology 42 (11), 1241, 2023 | 78 | 2023 |
| Genomic landscape and clinical utility in Korean advanced pan-cancer patients from prospective clinical sequencing: K-MASTER program KH Park, JY Choi, AR Lim, JW Kim, YJ Choi, S Lee, JS Sung, HJ Chung, ... Cancer Discovery 12 (4), 938-948, 2022 | 31 | 2022 |
| Incidence and predictors of febrile neutropenia among early-stage breast cancer patients receiving anthracycline-based chemotherapy in Korea HS Kim, SY Lee, JW Kim, YJ Choi, IH Park, KS Lee, JH Seo, SW Shin, ... Oncology 91 (5), 274-282, 2016 | 27 | 2016 |
| Completion rate of physician orders for life-sustaining treatment for patients with metastatic or recurrent cancer: a preliminary, cross-sectional study JW Kim, JY Choi, WJ Jang, YJ Choi, YS Choi, SW Shin, YH Kim, KH Park BMC palliative care 18, 1-9, 2019 | 20 | 2019 |
| Clinical application of targeted deep sequencing in metastatic colorectal cancer patients: actionable genomic alteration in K-MASTER project Y Lee, S Lee, JS Sung, HJ Chung, A Lim, JW Kim, YJ Choi, KH Park, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2021 | 19 | 2021 |
| Innovative countermeasures can maintain cancer care continuity during the coronavirus disease-2019 pandemic in Korea S Lee, A Lim, MJ Kim, YJ Choi, JW Kim, KH Park, SW Shin, YH Kim European Journal of Cancer 136, 69-75, 2020 | 15 | 2020 |
| PIK3CA mutation is associated with poor response to HER2-targeted therapy in breast cancer patients JW Kim, AR Lim, JY You, JH Lee, SE Song, NK Lee, SP Jung, KR Cho, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2023 | 13 | 2023 |
| Prognostic effects of cytokine levels on patients treated with taxane and zoledronic acid for metastatic breast cancer in bone (BEAT-ZO)(KCSG BR 10-13) JW Kim, S Lee, HS Kim, YJ Choi, J Yoo, KU Park, SY Kang, YH Park, ... Cytokine 142, 155487, 2021 | 11 | 2021 |
| A phase 2 multicenter study of docetaxel‐PM and trastuzumab‐pkrb combination therapy in recurrent or metastatic salivary gland carcinomas J Lee, S Park, HA Jung, SH Lee, S Seo, SB Kim, JW Kim, KW Lee, ... Cancer 129 (19), 2966-2974, 2023 | 8 | 2023 |
| Prediction of Axillary Lymph Node Metastasis in early-stage triple-negative breast Cancer using Multiparametric and Radiomic features of breast MRI SE Song, OH Woo, Y Cho, KR Cho, KH Park, JW Kim Academic Radiology 30, S25-S37, 2023 | 8 | 2023 |
| Clinical implication of concordant or discordant genomic profiling between primary and matched metastatic tissues in patients with colorectal cancer JY Choi, S Choi, M Lee, YS Park, JS Sung, WJ Chang, JW Kim, YJ Choi, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2020 | 7 | 2020 |
| Comparison of the data of a next-generation sequencing panel from K-MASTER project with that of orthogonal methods for detecting targetable genetic alterations YJ Choi, JY Choi, JW Kim, AR Lim, Y Lee, WJ Chang, S Lee, JS Sung, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2022 | 5 | 2022 |
| Aroma lymphatic massage (Aroma lymphatic tressage) for symptom relief in breast cancer patients with taxane acute pain syndrome: A randomized controlled crossover trial YS Ha, JW Kim, JE Lee, JH Yang, MJ Lee, EY Lee, JY You, SP Jung, ... European Journal of Integrative Medicine 54, 102167, 2022 | 4 | 2022 |
| Perception and safety analysis of COVID‐19 vaccination in cancer patients: A multicenter, real‐world study K Lee, IH Park, SC Oh, JH Seo, MJ Jeon, ES Yu, DS Kim, CW Choi, A Lim, ... Cancer medicine 12 (5), 5558-5568, 2023 | 2 | 2023 |
| Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation JW Kim, HE Kang, J Choi, SG Yun, SP Jung, SY Bae, JY You, YJ Choi, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2023 | 1 | 2023 |
| CC chemokine receptor 2-positive monocytic myeloid-derived suppressor cells predicts chemotherapeutic responses of the metastatic lesions in breast cancer patients JW Kim, JK Sa, SP Jung, KH Park, SI Park Cancer Research 83 (7_Supplement), 4349-4349, 2023 | | 2023 |
| Combination therapy of immune checkpoint inhibitor and HIF1α/c-MET peptide vaccine suppresses metastasis by modulating tumor microenvironment in triple-negative breast cancer JH Hong, J Lee, SY Lim, JW Kim, AR Lim, KH Park Cancer Research 83 (7_Supplement), 5087-5087, 2023 | | 2023 |
